T he relationship between alcohol consumption and acetaminophen hepatotoxicity is well-recognized, but the relationship between alcohol consumption and other causes of drug-induced liver injury (DILI) is less well-defined. 1, 2 Alcohol consumption is one of the criteria in the Roussel Uclaf Causality Assessment Method (RUCAM) causality instrument for assessing liver injury, 3, 4 although there is no evidence that alcohol consumption increases the risk from medications other than methotrexate, isoniazid, antiretroviral agents, or halothane. 5 Heavy alcohol consumption is believed to increase the risk of liver damage in individuals taking methotrexate long-term. 6, 7 Chronic alcohol abuse may increase the risk of liver injury from anti-tuberculosis agents, 8, 9 but not all studies have shown a significant relationship between alcohol consumption and liver injury from anti-tuberculosis medications. [10] [11] [12] The labeling for duloxetine, a frequently prescribed antidepressant, recommends that individuals with substantial alcohol consumption should not take this medication, 13 although there is no published evidence to support this recommendation. In an earlier study from the Drug-Induced Liver Injury Network (DILIN), alcohol consumption, defined as any alcohol intake in the preceding 12 months, was unexpectedly associated with less severe injury in individuals with DILI. 14 To better understand the relationship between alcohol consumption and DILI, we investigated the relationship between heavy alcohol consumption and the causative agents, characteristics, and outcomes of patients with DILI enrolled in the DILIN Prospective Study.
Methods
Initiated in 2004, the DILIN Prospective Study (NCT00345930) enrolled individuals !2 years old with suspected DILI at several clinical centers across the United States. The inclusion and exclusion criteria, evaluation for competing etiologies, follow-up, and causality and severity assessment have been described in previous publications. [14] [15] [16] Several publications have resulted from the DILIN Prospective Study during the last decade, so that many participants included in this analysis were included in previous publications. [17] [18] [19] [20] [21] The DILIN Prospective Study was approved by the Institutional Review Boards of the enrolling clinical centers, and all participants provided written informed consent. In addition, the protocol and consent form were approved and the study was monitored by an independent data and safety monitoring board appointed by the National Institutes of Health.
This analysis consisted of individuals enrolled between September 2004 and April 2016 who were judged to have definite, highly likely, or probable DILI. At the time of enrollment, participants were questioned about their alcohol consumption, and a trained interviewer administered a shortened version of the Skinner Alcohol Dependence Scale to individuals with any reported alcohol use within the preceding 12 months. [22] [23] [24] This questionnaire obtained the following details of participants' alcohol consumption history during 5 years before the DILI event: time and age range of alcohol consumption, drinks per day, drinking days per month, type of alcohol consumed, pattern of alcohol consumption (occasional, daily, weekend, binge), any life events influencing alcohol consumption, and perception of effect of alcohol consumption on their lives. For this analysis, heavy alcohol consumption was defined as regular average consumption of more than 2 drinks per day for women and more than 3 drinks per day for men.
Statistics
Demographic and clinical data for subjects enrolled in the DILIN Prospective Study between September 2004 and April 2016 were extracted on September 9, 2016.
Descriptive statistics, such as means with standard deviations, median with interquartile ranges, and frequency distributions, were used to characterize the cohort. Differences between groups were tested by using the c 2 test for categorical variables and Wilcoxon/Kruskal-Wallis test for the continuous variables. The primary outcomes of interest were (1) DILIN severity score, (2) liver transplantation or liver-related death, and (3) chronic DILI. Other outcomes of interest were severity of liver injury and causality assessment categories. Primary comparison was between individuals with heavy alcohol consumption and those without any alcohol consumption. Other comparisons were between (1) individuals with heavy drinking and those with non-heavy drinking and (2) individuals with and without any reported alcohol consumption. Statistical analyses were performed by using SAS software, version 9.2 (SAS Institute, Cary, NC); P values <.05 were considered statistically significant, and P values between .05 and .10 were considered to show trends toward significance.
Results
The DILIN Prospective Study enrolled 1723 participants between September 2004 and April 2016, and 1512 had undergone 6-month follow-up and causality adjudication before September 9, 2016. Of this total, 1198 participants were judged to have definite, highly likely, or probable DILI and constituted the study cohort (Figure 1 ). At least some alcohol consumption was reported by 601 individuals, whereas 597 reported no alcohol consumption in the preceding 12 months. The 601 participants were invited to complete the alcohol consumption questionnaire, and 348 (58%) agreed. There were no significant differences in the demographics and clinical characteristics of individuals with reported consumption who did (n ¼ 348) and did not (n ¼ 253) complete the alcohol consumption questionnaire (Supplementary Table 1 ). Of 348 individuals who completed the alcohol consumption questionnaire, 80 individuals reported heavy consumption. The frequency of preexisting liver disease was 11% in nondrinkers, 9% in non-heavy drinkers, and 11% in heavy drinkers (P ¼ NS). The frequency of heavy drinking among individuals with DILI who had known preexisting liver disease was 10.6%.
Comparison Between Individuals With Heavy Alcohol Consumption and Without Any Alcohol Consumption
Compared with individuals with no alcohol consumption, participants with heavy consumption were younger (mean age, 42 vs 49 years) and more likely men (52% vs 35%), but their self-reported race and their body mass indices were not different (Table 1) . Individuals with heavy alcohol consumption had lower frequency of diabetes mellitus (13% vs 28%, P ¼ .003), but the prevalence of preexisting liver disease was not different (11% in both groups). The latency to onset and the pattern of liver injury at presentation were similar between the 2 groups. Individuals with heavy alcohol consumption had significantly higher peak serum alanine aminotransferase (ALT) and total bilirubin levels, but mean alkaline phosphatase or international normalized ratio (INR) values were similar, as were the times to improvements in biochemical abnormalities.
The most commonly implicated therapeutic classes and specific agents are shown in Table 2 . Interestingly, anabolic steroids were the most common cause of DILI in individuals with heavy alcohol consumption (13%), whereas they accounted for few cases (2%) in those without alcohol consumption (P < .001). Nevertheless, the overall characteristics (eg, latency, pattern of liver injury, peak enzymes, pattern of recovery), severity, and outcomes of liver injury due to anabolic steroids were not significantly different between individuals with heavy alcohol consumption (n ¼ 10) and those without alcohol consumption (n ¼ 12) (data not shown). The frequency of liver injury due to isoniazid was not different between the 2 groups (6.3% in the heavy alcohol group vs 5% in those without alcohol consumption; P ¼ .8).
Causality assessment and the proportion of cases judged to be definite vs highly likely vs possible were similar in the 2 groups (P ¼ .40; Table 3 ). Although the overall distribution of severity scores was not different in the 2 groups, cases that were scored as severe or fatal were more frequent among those with heavy alcohol consumption compared with non-drinkers (36% vs 28%), as were numbers of death or liver transplantation (10% vs 6%; P ¼ .18), but these differences were not statistically significant (P ¼ .53). Finally, chronicity as defined as continued evidence of liver injury at 6 months after onset was similar in frequency between the 2 groups (18% vs 15%; P ¼ .53).
Comparison Between Individuals With Heavy Drinking and Those With Non-heavy Drinking
Comparison of patients with mild or moderate alcohol intake with those with heavy consumption demonstrated similar differences to those comparing non-drinkers with heavy drinkers (Table 1 or 2), although the statistical significance of the differences was less, perhaps because of the fewer number of non-heavy drinkers. Thus, latency, pattern of liver injury, and time to recovery among the 80 individuals with heavy alcohol consumption compared with the 268 individuals with non-heavy alcohol consumption were similar, but mean peak ALT, total bilirubin, and INR values were higher in patients with heavy alcohol consumption (Tables 1 and 3 ). Subjects with heavy alcohol consumption had trends toward more severe liver injury with higher average DILIN severity scores (2.9 vs 2.6; P ¼ .06) but did not have higher likelihood of fatalities or liver transplantation (10% vs 6.3%; P ¼ .27). Anabolic steroids were more frequently implicated in cases among those with heavy alcohol intake than those with less than heavy intake (13% vs 5%) ( Table 2) .
Comparison Between Individuals With and Without Any Reported Alcohol Consumption
There were 601 individuals who reported any alcohol consumption, whereas 597 consumed no alcohol in preceding 12 months (Supplementary Table 2 ). Their age and body mass indices were similar, but there were fewer women in the individuals with alcohol consumption. Individuals with alcohol consumption had lower prevalence of diabetes mellitus, but the prevalence of preexisting liver disease was similar between the 2 groups. The frequency of liver injury due to herbal and dietary supplements was significantly higher in individuals with alcohol consumption than those without alcohol consumption (21.5% vs 14.4%; P < .001). The latency between initiating the suspected agent and DILI recognition and the pattern of liver injury at presentation was similar between the 2 groups. Compared with those without alcohol consumption, individuals with alcohol consumption had significantly higher peak serum ALT values but lower INR. Interestingly, individuals with alcohol consumption had lower DILIN severity score compared with those without alcohol consumption (2.6 AE 1.2 vs 2.7 AE 1.2; P ¼ .032), but liver-related death or need for liver transplantation (7% vs 6.2%; P ¼ .6) and chronic DILI (15.3% vs 18.3%; P ¼ .2) were similar between the 2 groups (Supplementary Table 2 ).
Alcohol Consumption and Liver Injury due to Isoniazid
Because it has been suggested that alcohol consumption is a possible risk factor for isoniazid hepatotoxicity, we examined whether there was an association between alcohol consumption and isoniazid hepatotoxicity in our cohort. The proportion of liver injury attributed to isoniazid among heavy drinkers was 6.3%, and it was not significantly different from non-drinkers (5%; P ¼ .6) or non-heavy drinkers (2.2%; P ¼ .13).
Death or Liver Transplantation Among Heavy Drinkers With Drug-induced Liver Injury
Two individuals with a history of heavy alcohol consumption died as a result of their liver injury, and 6 others underwent liver transplantation for acute liver injury ( Table 4 ). The 2 fatal cases consisted of a 44-yearold man with underlying alcoholic cirrhosis and steatohepatitis who developed acute-on-chronic liver failure 11 days after initiating niacin and a 76-year-old man with chronic obstructive pulmonary disease who received azithromycin for a bronchitis flare and developed severe Alk P, serum alkaline phosphatase; ALT, serum alanine aminotransferase; BMI, body mass index; Chol, cholestatic; DILI, drug-induced liver injury; HC, hepatocellular; INR, international normalized ratio; IQR, interquartile range (25%-75%); SD, standard deviation; ULN, upper limit of normal.
liver injury and skin rash 6 days after initiating azithromycin, rapidly developing acute liver failure and dying 3 weeks later with multiorgan failure. Anti-hepatitis C virus and hepatitis C virus RNA were negative in all 8 patients who died or received transplantation. Anti-hepatitis E virus immunoglobulin G was negative in 6 patients and was positive in patients but without detectable anti-hepatitis E virus immunoglobulin M. It appeared that 3 patients had underlying alcoholic liver disease and developed superimposed acute-on-chronic liver failure, whereas 5 others developed acute liver failure to DILI without clinical evidence of preexisting alcoholic liver disease.
Analyses Without Individuals With Probable Drug-induced Liver Injury
When probable DILI cases were excluded, there were 445 non-drinkers, 205 non-heavy drinkers, and 63 heavy drinkers, and their DILIN severity scores were 2.7 AE 1.2, 2.5 AE 1.1, and 2.9 AE 1.2, respectively. Although there was no difference in the DILIN severity score between non-drinkers and heavy drinkers (P ¼ .33), it was significantly higher in heavy drinkers compared with non-heavy drinkers (P ¼ .03). There was no difference in liver-related deaths or liver transplantation (nondrinkers 4%, non-heavy drinkers 5.3%, and heavy Explant showed submassive necrosis and no evidence of underlying cirrhosis. This case was reported previously as case 2 in the report by Heidemann et al. 30 DILIN, Drug-induced Liver Network; F, female; M, male.
a All patients were white except for the 45-year-old woman with isoniazid-induced liver injury whose race and ethnicity are not available. drinkers 6.3%; P ¼ .33 vs non-drinkers; P ¼ .75 vs nonheavy drinkers) or chronic DILI (non-drinkers 15.9%, non-heavy drinkers 16.7%, and heavy drinkers 12.7%; P ¼ .55 vs non-drinkers; P ¼ .48 vs non-heavy drinkers).
Discussion
Although there is a large body of literature investigating the role of alcohol consumption and acetaminophen hepatotoxicity, there is scant literature examining the relationship between alcohol consumption and idiosyncratic DILI. In this report, we comprehensively examined the relationship between heavy and non-heavy alcohol consumption and causative agents, characteristics, and outcomes of liver injury in a large cohort of prospectively enrolled patients with well-characterized DILI. Our main observations are (1) DILI in individuals with heavy alcohol consumption did not necessarily result in significantly higher frequency of liver-related deaths or required liver transplantation, compared with those without any alcohol consumption; (2) there was significant enrichment of anabolic steroid-related liver injury in subjects with heavy alcohol consumption; and (3) individuals who reported any alcohol consumption tended to have lower DILIN severity score, but their outcomes were not different from those who reported no alcohol consumption.
The higher frequency of liver injury due to anabolic steroids in patients with heavy alcohol consumption may simply represent a behavioral association rather than any pathophysiological link between the two. These behaviors are more frequent in younger men. In a recent comprehensive literature review, Dodge and Hoagland 25 observed a strong bivariate relationship between anabolic androgenic steroid abuse and alcohol use. The lifetime use of anabolic androgenic steroid was positively associated with recent as well as lifetime alcohol use, problem/harmful drinking, and binge drinking. 25 Nevertheless, our study cannot exclude the possibility that heavy alcohol consumption increases the risk of developing liver injury caused by anabolic steroids.
The relationship between isoniazid hepatotoxicity and chronic alcohol consumption in the published literature has not been consistent. Some studies found significant association between chronic alcohol consumption and liver injury due to isoniazid or antituberculosis drugs, 8, 9, 26 whereas this relationship could not be demonstrated in other studies. [10] [11] [12] In our study, liver injury due to isoniazid among individuals with heavy alcohol consumption was not more common than those with no alcohol consumption or mild to moderate alcohol consumption, but our study was not designed to specifically investigate alcohol consumption as a risk factor for isoniazid hepatotoxicity.
One of the instruments frequently used to adjudicate the causality in patients with suspected DILI is RUCAM, and it is based on 7 domains including age, alcohol, or pregnancy as risk factors. 27 There is emerging consensus among the experts that alcohol consumption is not necessarily a risk factor for idiosyncratic DILI, and arguably it should not be a criterion in assigning causality in suspected DILI. 28 Although our study represents a detailed description of the relationship between DILI and alcohol consumption, because it included only patients with suspected DILI, it is not able to assess whether alcohol consumption is a risk factor for DILI or its inclusion as one of the criteria in the RUCAM instrument.
Some aspects of our study design deserve further discussion. Our study consists of patients presenting to select clinical centers with well-characterized DILI, and thus it cannot address the causal relationship between alcohol consumption and all-cause DILI or liver injury caused by specific agents. Also, our study is based on self-reported alcohol use, which may underestimate the frequency and extent of alcohol consumption, but unfortunately, there are no other practical methods to capture the details of alcohol consumption in studies of this nature. We also focus our discussion on the differences between non-drinkers and heavy drinkers where misclassification bias is probably lower. We had a significant number of patients who did not complete a Skinner questionnaire, but they did not differ significantly in terms of other clinical and demographic features. Counterbalancing these issues are the DILIN's unique strengths such as prospective study design, larger sample size, well-characterized DILI phenotype, and careful, structured adjudication of causality and severity.
In summary, anabolic steroids are the most common cause of DILI in individuals with heavy alcohol consumption. We did not find heavy alcohol consumption to be associated with worse outcomes in patients with DILI. Furthermore, there was no evidence for heavy alcohol consumption as a risk factor for liver injury due to isoniazid in this experience.
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